Anderson, C J <br/><br/>
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.  [electronic resource] 

 -  Journal of nuclear medicine : official publication, Society of Nuclear Medicine  Feb 2001 
 - 213-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0161-5505 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoma, Islet Cell--diagnostic imaging<br/>Aged<br/>Animals<br/>Carcinoid Tumor--diagnostic imaging<br/>Female<br/>Gastrointestinal Neoplasms--diagnostic imaging<br/>Humans<br/>Indium Radioisotopes<br/>Male<br/>Middle Aged<br/>Neuroendocrine Tumors--chemistry<br/>Octreotide--analogs & derivatives<br/>Organometallic Compounds--pharmacokinetics<br/>Pancreatic Neoplasms--diagnostic imaging<br/>Papio<br/>Pentetic Acid--analogs & derivatives<br/>Radiation Dosage<br/>Radiopharmaceuticals<br/>Receptors, Somatostatin--analysis<br/>Sensitivity and Specificity<br/>Tomography, Emission-Computed